Radical radiotherapy for urinary bladder cancer: treatment outcomes

References

• Aben KK, Kiemeney LA. Epidemiology of bladder cancer. Eur. Urol. 36(6), 660–672 (1999).
   PubMedGoogle Scholar
• Sundhedsstyrelsen: København. Cancerregisteret 2001–2002. Danish National Board of Health, Denmark (2004).
   Google Scholar
• Tjonneland A, Skov T, Mellemgaard A. Survival of Danish cancer patients 1943–1987. Urinary tract. APMIS 33(Suppl.), 137–148 (1993).
   Google Scholar
• Shelley MD, Wilt TJ, Barber J, Mason MD. A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice? Clin. Oncol. 16(3), 166–171 (2004).
   Web of Science ®Google Scholar
• Bloom HJ, Hendry WF, Wallace DM, Skeet RG. Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Br. J. Urol. 54(2), 136–151 (1982).
   PubMedGoogle Scholar
• Miller LS. Bladder cancer: superiority of preoperative irradiation and cystectomy in clinical stages B2 and C. Cancer 39(Suppl. 2), 973–980 (1977).
   PubMed Web of Science ®Google Scholar
• Sell A, Jakobsen A, Nerstrom B et al. Treatment of advanced bladder cancer category T2 T3 and T4a. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Danish Vesical Cancer Group. Scand. J. Urol. Nephrol. 138, 193–201 (1981).
   Google Scholar
• Cheng L, Neumann RM, Weaver AL et al. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am. J. Clin. Pathol. 113(2), 275–279 (2000).
   PubMed Web of Science ®Google Scholar
• Dutta SC, Smith JA Jr, Shappell SB et al. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J. Urol. 166(2), 490–493 (2001).
   PubMed Web of Science ®Google Scholar
• Pagano F, Bassi P, Galetti TP et al. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J. Urol. 145(1), 45–50 (1991).
   PubMed Web of Science ®Google Scholar
• Fokdal L, Hoyer M, von der Maase H. Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer. Acta Oncol. 43(8), 749–757 (2004).
   PubMed Web of Science ®Google Scholar
• Fossa SD, Ous S, Espetveit S, Langmark F. Patterns of primary care and survival in 336 consecutive unselected Norwegian patients with bladder cancer. Scand. J. Urol. Nephrol. 26(2), 131–138 (1992).
   PubMed Web of Science ®Google Scholar
• Fossa SD, Waehre H, Aass N et al. Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients. Cancer 72(10), 3036–3043 (1993).
   PubMed Web of Science ®Google Scholar
• Jahnson S, Pedersen J, Westman G. Bladder carcinoma – a 20-year review of radical irradiation therapy. Radiother. Oncol. 22(2), 111–117 (1991).
   PubMed Web of Science ®Google Scholar
• Jenkins BJ, Caulfield MJ, Fowler CG et al. Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer. Br. J. Urol. 62(4), 343–346 (1988).
   PubMedGoogle Scholar
• Sengelov L, Klintorp S, Havsteen H et al. Treatment outcome following radiotherapy in elderly patients with bladder cancer. Radiother. Oncol. 44(1), 53–58 (1997).
   PubMed Web of Science ®Google Scholar
• Davidson SE, Symonds RP, Snee MP et al. Assessment of factors influencing the outcome of radiotherapy for bladder cancer. Br. J. Urol. 66(3), 288–293 (1990).
   PubMedGoogle Scholar
• Duncan W, Quilty PM. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage x ray therapy. Radiother. Oncol. 7(4), 299–310 (1986).
   PubMed Web of Science ®Google Scholar
• Mameghan H, Fisher RJ, Watt WH et al. The management of invasive transitional cell carcinoma of the bladder. Results of definitive and preoperative radiation therapy in 390 patients treated at the Prince of Wales Hospital, Sydney, Australia. Cancer 69(11), 2771–2778 (1992).
   PubMed Web of Science ®Google Scholar
• Pollack A, Zagars GK, Swanson DA. Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors. Int. J. Radiat. Oncol. Biol. Phys. 30(2), 267–277 (1994).
   PubMed Web of Science ®Google Scholar
• Scrimger RA, Murtha AD, Parliament MB et al. Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors. Int. J. Radiat. Oncol. Biol. Phys. 51(1), 23–30 (2001).
   PubMed Web of Science ®Google Scholar
• Smaaland R, Akslen LA, Tonder B et al. Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients. Br. J. Urol. 67(1), 61–69 (1991).
   PubMedGoogle Scholar
• Bell CR, Lydon A, Kernick V et al. Contemporary results of radical radiotherapy for bladder transitional cell carcinoma in a district general hospital with cancer-centre status. BJU Int. 83(6), 613–618 (1999).
   PubMed Web of Science ®Google Scholar
• Blandy JP, England HR, Evans SJ et al. T3 bladder cancer – the case for salvage cystectomy. Br. J. Urol. 52(6), 506–510 (1980).
   PubMedGoogle Scholar
• Chahal R, Sundaram SK, Iddenden R et al. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. Eur. Urol. 43(3), 246–257 (2003).
   PubMed Web of Science ®Google Scholar
• Goodman GB, Hislop TG, Elwood JM, Balfour J. Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy. Int. J. Radiat. Oncol. Biol. Phys. 7(5), 569–573 (1981).
   PubMed Web of Science ®Google Scholar
• Hayter CR, Paszat LF, Groome PA et al. A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer. Int. J. Radiat. Oncol. Biol. Phys. 45(5), 1239–1245 (1999).
   PubMed Web of Science ®Google Scholar
• Gospodarowicz MK, Hawkins NV, Rawlings GA et al. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. J. Urol. 142(6), 1448–1453 (1989).
   PubMed Web of Science ®Google Scholar
• Goffinet DR, Schneider MJ, Glatstein EJ et al. Bladder cancer: results of radiation therapy in 384 patients. Radiology 117(1), 149–153 (1975).
   PubMed Web of Science ®Google Scholar
• Moonen L, Voet H, de Nijs R et al. Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control. Int. J. Radiat. Oncol. Biol. Phys. 42(3), 525–530 (1998).
   PubMed Web of Science ®Google Scholar
• Salminen E. External beam radiation treatment of urinary bladder carcinoma. An analysis of results in 203 patients. Acta Oncol. 29(7), 909–914 (1990).
   PubMed Web of Science ®Google Scholar
• Shipley WU, Prout GR Jr, Einstein AB et al. Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 258(7), 931–935 (1987).
   PubMed Web of Science ®Google Scholar
• Dershaw DD, Panicek DM. Imaging of invasive bladder cancer. Semin. Oncol. 17(5), 544–550 (1990).
   PubMed Web of Science ®Google Scholar
• Greven KM, Solin LJ, Hanks GE. Prognostic factors in patients with bladder carcinoma treated with definitive irradiation. Cancer 65(4), 908–912 (1990).
   PubMed Web of Science ®Google Scholar
• Shipley WU, Rose MA, Perrone TL et al. Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. J. Urol. 134(4), 679–683 (1985).
   PubMed Web of Science ®Google Scholar
• Holmang S, Hedelin H, Borghede G, Johansson SL. Long-term follow-up of a bladder carcinoma cohort: questionable value of radical radiotherapy. J. Urol. 157(5), 1642–1646 (1997).
   PubMed Web of Science ®Google Scholar
• De Neve W, Lybeert ML, Goor C et al. Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time. Radiother. Oncol. 36(3), 183–188 (1995).
   PubMed Web of Science ®Google Scholar
• Vazina A, Dugi D, Shariat SF et al. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J. Urol. 171(5), 1830–1834 (2004).
   PubMed Web of Science ®Google Scholar
• Fish JC, Fayos JV. Carcinoma of the urinary bladder. Influence of dose and volume irradiated on survival. Radiology 118(1), 179–182 (1976).
   PubMed Web of Science ®Google Scholar
• Logue JP, Sharrock CL, Cowan RA et al. Clinical variability of target volume description in conformal radiotherapy planning. Int. J. Radiat. Oncol. Biol. Phys. 41(4), 929–931 (1998).
   PubMed Web of Science ®Google Scholar
• Meijer GJ, Rasch C, Remeijer P, Lebesque JV. Three-dimensional analysis of delineation errors, set-up errors, and organ motion during radiotherapy of bladder cancer. Int. J. Radiat. Oncol. Biol. Phys. 55(5), 1277–1287 (2003).
   PubMed Web of Science ®Google Scholar
• International Commission on Radiation Units and Measurement. Prescribing, Recording, and Reporting Photon Beam Therapy, ICRU Report 62 (Supplement to ICRU Report 50). ICRU, Washington DC, USA (1999).
   Google Scholar
• Turner SL, Swindell R, Bowl N et al. Bladder movement during radiation therapy for bladder cancer: implications for treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 39(2), 355–360 (1997).
   PubMed Web of Science ®Google Scholar
• Harris SJ, Buchanan RB. An audit and evaluation of bladder movements during radical radiotherapy. Clin. Oncol. 10(4), 262–264 (1998).
   PubMedGoogle Scholar
• Sur RK, Clinkard J, Jones WG et al. Changes in target volume during radiotherapy treatment of invasive bladder carcinoma. Clin. Oncol. 5(1), 30–33 (1993).
   Google Scholar
• Pos FJ, Koedooder K, Hulshof MC et al. Influence of bladder and rectal volume on spatial variability of a bladder tumor during radical radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 55(3), 835–841 (2003).
   PubMed Web of Science ®Google Scholar
• Fokdal L, Honore H, Hoyer M et al. Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer. Int. J. Radiat. Oncol. Biol. Phys. 59(2), 436–444 (2004).
   PubMed Web of Science ®Google Scholar
• Muren LP, Redpath AT, McLaren DB. Treatment margins and treatment fractionation in conformal radiotherapy of muscle-invading urinary bladder cancer. Radiother. Oncol. 71(1), 65–71 (2004).
   PubMed Web of Science ®Google Scholar
• Quilty PM, Duncan W. Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control. Int. J. Radiat. Oncol. Biol. Phys. 12(6), 853–860 (1986).
   PubMed Web of Science ®Google Scholar
• Widmark A, Flodgren P, Damber JE et al. A systematic overview of radiation therapy effects in urinary bladder cancer. Acta Oncol. 42(5–6), 567–581 (2003).
   PubMed Web of Science ®Google Scholar
• Scholten AN, Leer JW, Collins CD et al. Hypofractionated radiotherapy for invasive bladder cancer. Radiother. Oncol. 43(2), 163–169 (1997).
   PubMed Web of Science ®Google Scholar
• Jose CC, Price A, Norman A et al. Hypofractionated radiotherapy for patients with carcinoma of the bladder. Clin. Oncol. 11(5), 330–333 (1999).
   PubMed Web of Science ®Google Scholar
• Cox JD, Guse C, Asbell S et al. Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of Protocol 83–08 of the Radiation Therapy Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 15(6), 1331–1336 (1988).
   PubMed Web of Science ®Google Scholar
• Edsmyr F, Andersson L, Esposti PL et al. Irradiation therapy with multiple small fractions per day in urinary bladder cancer. Radiother. Oncol. 4(3), 197–203 (1985).
   PubMed Web of Science ®Google Scholar
• Naslund I, Nilsson B, Littbrand B. Hyperfractionated radiotherapy of bladder cancer. A ten-year follow-up of a randomized clinical trial. Acta Oncol. 33(4), 397–402 (1994).
   PubMed Web of Science ®Google Scholar
• Fowler JF. Biological factors influencing optimum fractionation in radiation therapy. Acta Oncol. 40(6), 712–717 (2001).
   PubMed Web of Science ®Google Scholar
• Maciejewski B, Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother. Oncol. 21(3), 163–170 (1991).
   PubMed Web of Science ®Google Scholar
• Kob D, Kloetzer KH, Kriester A et al. Results of radiotherapeutic optimization within the scope of combined operative-radiologic therapy of urinary bladder cancer. Z. Urol. Nephrol. 78(10), 545–550 (1985).
   PubMedGoogle Scholar
• Marcial VA, Amato DA, Brady LW et al. Split-course radiotherapy of carcinoma of the urinary bladder stages C and D1. A Radiation Therapy Oncology Group Study. Am. J. Clin. Oncol. 8(3), 185–199 (1985).
   PubMed Web of Science ®Google Scholar
• Salminen E. Split-course radiotherapy for urinary bladder cancer. Radiother. Oncol. 15(4), 327–331 (1989).
   PubMed Web of Science ®Google Scholar
• Quilty PM, Duncan W, Chisholm GD et al. Results of surgery following radical radiotherapy for invasive bladder cancer. Br. J. Urol. 58(4), 396–405 (1986).
   PubMedGoogle Scholar
• von der Maaase H, Sengelov L. Chemotherapy in locally anvanced and metastatic bladder cancer. Am. J. Cancer 4, 1–13 (2005).
   Google Scholar
• von der Maase H. Gemcitabine in transitional cell carcinoma of the urothelium. Expert Rev. Anticancer Ther. 3(1), 11–19 (2003).
   PubMedGoogle Scholar
• Fokdal L, Honore H, Hoyer M, von der Maase H. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy. Radiother. Oncol. 74(2), 203–210 (2005).
   PubMed Web of Science ®Google Scholar
• Tait DM, Nahum AE, Meyer LC et al. Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment. Radiother. Oncol. 42(2), 121–136 (1997).
   PubMed Web of Science ®Google Scholar
• Abrahamsen JF, Fossa SD. Long-term morbidity after curative radiotherapy for carcinoma of the bladder. A retrospective study. Strahlenther Onkol. 166(9), 580–583 (1990).
   PubMedGoogle Scholar
• Caffo O, Fellin G, Graffer U, Luciani L. Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. A survey by a self-administered questionnaire. Cancer 78(5), 1089–1097 (1996).
   PubMed Web of Science ®Google Scholar
• Henningsohn L, Wijkstrom H, Dickman PW et al. Distressful symptoms after radical radiotherapy for urinary bladder cancer. Radiother. Oncol. 62(2), 215–225 (2002).
   PubMed Web of Science ®Google Scholar
• Zietman AL, Sacco D, Skowronski U et al. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J. Urol. 170(5), 1772–1776 (2003).
   PubMed Web of Science ®Google Scholar
• Fokdal L, Hoyer M, Meldgaard P, von der Maase H. Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer. Radiother. Oncol. 72(2), 139–145 (2004).
   PubMed Web of Science ®Google Scholar
• Emami B, Lyman J, Brown A et al. Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 21(1), 109–122 (1991).
   PubMed Web of Science ®Google Scholar
• Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 31(5), 1257–1280 (1995).
   PubMed Web of Science ®Google Scholar
• Cozzarini C, Fiorino C, Ceresoli GL et al. Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6–70.2 Gy). Int. J. Radiat. Oncol. Biol. Phys. 55(3), 688–694 (2003).
   PubMed Web of Science ®Google Scholar
• Fenwick JD, Khoo VS, Nahum AE et al. Correlations between dose–surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 49(2), 473–480 (2001).
   PubMed Web of Science ®Google Scholar
• Fiorino C, Cozzarini C, Vavassori V et al. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. Radiother. Oncol. 64(1), 1–12 (2002).
   PubMed Web of Science ®Google Scholar
• Greco C, Mazzetta C, Cattani F et al. Finding dose–volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer. Radiother. Oncol. 69(2), 215–222 (2003).
   PubMed Web of Science ®Google Scholar
• al Abany M, Helgason AR, Cronqvist AK et al. Dose to the anal sphincter region and risk of fecal leakage. Acta Oncol. 43(1), 117–118 (2004).
   PubMed Web of Science ®Google Scholar
• Smith JA Jr, Crawford ED, Paradelo JC et al. Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a Phase III intergroup study. J. Urol. 157(3), 805–807 (1997).
   PubMed Web of Science ®Google Scholar
• Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J. Clin. Oncol. 19(3), 666–675 (2001).
   PubMed Web of Science ®Google Scholar
• Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 361(9373), 1927–1934 (2003).
   PubMed Web of Science ®Google Scholar
• Sumiyoshi Y. Chemoradiotherapy as a bladder-preservation approach for muscle-invasive bladder cancer: current status and perspectives. Int. J. Clin. Oncol. 9(6), 484–490 (2004).
   PubMedGoogle Scholar
• Rodel C, Grabenbauer GG, Kuhn R et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J. Clin. Oncol. 20(14), 3061–3071 (2002).
   PubMed Web of Science ®Google Scholar
• Shipley WU, Kaufman DS, Tester WJ et al. Overview of bladder cancer trials in the Radiation Therapy Oncology Group. Cancer 97(Suppl. 8), 2115–2119 (2003).
   PubMed Web of Science ®Google Scholar
• Freiha F, Reese J, Torti FM. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J. Urol. 155(2), 495–499 (1996).
   PubMed Web of Science ®Google Scholar
• Shearer RJ, Chilvers CF, Bloom HJ et al. Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report. Br. J. Urol. 62(6), 558–564 (1988).
   PubMedGoogle Scholar
• Skinner DG, Daniels JR, Russell CA et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J. Urol. 145(3), 459–464 (1991).
   PubMed Web of Science ®Google Scholar
• Stockle M, Meyenburg W, Wellek S et al. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. J. Urol. 153(1), 47–52 (1995).
   PubMed Web of Science ®Google Scholar
• Duchesne GM, Bolger JJ, Griffiths GO et al. A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09. Int. J. Radiat. Oncol. Biol. Phys. 47(2), 379–388 (2000).
   PubMed Web of Science ®Google Scholar
• Fossa SD, Hosbach G. Short-term moderate-dose pelvic radiotherapy of advanced bladder carcinoma. A questionnaire-based evaluation of its symptomatic effect. Acta Oncol. 30(6), 735–738 (1991).
   PubMed Web of Science ®Google Scholar
• McLaren DB, Morrey D, Mason MD. Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly. Radiother. Oncol. 43(2), 171–174 (1997).
   PubMed Web of Science ®Google Scholar
• Salminen E. Unconventional fractionation for palliative radiotherapy of urinary bladder cancer. A retrospective review of 94 patients. Acta Oncol. 31(4), 449–454 (1992).
   PubMed Web of Science ®Google Scholar
• Holmang S, Borghede G. Early complications and survival following short-term palliative radiotherapy in invasive bladder carcinoma. J. Urol. 155(1), 100–102 (1992).
   Google Scholar